Seminars in Oncology
Volume 30, Issue 2 , Pages 107-109 , April 2003

Defining Waldenstrom's macroglobulinemia

References 

  1. Waldenström J. Incipient myelomatosis or essential hyperglobulinemia with fibrinogenopenia—A new syndrome?. Acta Med Scand. 1944;117:217–247
  2. Groves FD, Travis LB, Devesa SS, et al.  Waldenstrom's macroglobulinemia. incidence patterns in the Unites States, 1988-1994. Cancer. 1998;82:1078–1081
  3. Harris NL, Jaffe ES, Stein H. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood. 1994;84:1361–1392
  4. Harris NL, Jaffe ES, Diebold J, et al.  World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting—Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835–3849
  5. Owen RG, Treon SP, Al-Katib A, et al.  Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's macroglobulinemia. Semin Oncology. 2003;30:110–115
  6. Kyle RA, Treon SP, Alexanian R, et al.  Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's macroglobulinemia. Semin Oncol. 2003;30:116–120
  7. Gertz M, Anagnostopoulos A, Anderson KC, et al.  Treatment Recommendations in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's macroglobulinemia. Semin Oncol. 2003;30:121–126
  8. Weber D, Treon SP, Emmanouilides C, et al.  Uniform response criteria in Waldenstrom's Macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol. 2003;30:127–131
  9. Schop RFJ, Fonseca R. Genetics and cytogenetics of Waldenstrom's macroglobulinemia. Semin Oncol. 2003;30:142–145
  10. Avet-Loiseau H, Garand R, Lode L, et al.  14q32 translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia. Semin Oncol. 2003;30:153–155
  11. Kriangkum J, Taylor BJ, Mant MJ, et al.  The malignant clone in Waldenstrom's macroglobulinemia. Semin Oncol. 2003;30:132–135
  12. Sahota SS, Forconi F, Ottensmeier CH, et al.  Origins of the malignant clone in typical Waldenstrom's macroglobulinemia. Semin Oncol. 2003;30:136–141

☆ Address reprint requests to Steven P. Treon, MD, MA, PhD, Waldenstrom's Macroglobulinemia Program, Dana Farber Cancer Institute, LG100, 44 Binney St, Boston, MA 02115.

☆☆ 0093-7754/03/3002-0046$30.00/0

PII: S0093-7754(03)70058-X

doi: 10.1053/sonc.2003.50081

Seminars in Oncology
Volume 30, Issue 2 , Pages 107-109 , April 2003

Article Tools

* Image Usage & Resolution